Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on LongTermValue Research’s Substack. In ...

Veeva Systems has built its presence in brand engagement with the acquisition of Ostro, a tech start-up that helps pharma companies connect with doctors and patients using AI-powered conversational ...

The deal signals Veeva’s push to expand artificial intelligence tools that help pharmaceutical brands interact with patients and healthcare professionals. The transaction adds an AI-powered engagement ...

Combining Claude Code with Obsidian creates a structured yet adaptable system for managing information and projects. In a recent breakdown, Chase AI explores how this integration uses Obsidian’s ...

With broad industry success and the availability of Veeva AI, Vault CRM is the leader in agentic CRM for life sciences PLEASANTON, Calif., March 3, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) ...

Veeva's laser focus on the life sciences industry has made it a leader in this corner of the cloud market. The company could grow its revenue -- and share price -- at a good clip in the next four ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Veeva Systems (NYSE:VEEV) reports that 13 of the top 20 ...

PLEASANTON, Calif., Jan. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Novo Nordisk's International Operations business unit has committed to use Veeva Vault CRM. "We are ...

Overview of Veeva Systems’ role in the industrial life sciences software sector Examination of Vault platform and operational capabilities across global markets Insights into cloud infrastructure, ...

Veeva Systems (NYSE: VEEV) is currently in Phase 18, the final stage of its 18-phase Adhishthana cycle on the weekly charts. The company recently reported earnings, and the stock has fallen sharply ...

I reiterate my 'Buy' rating on Veeva Systems, driven by accelerating Vault CRM adoption and robust R&D Solutions growth. VEEV's successful enterprise migrations and a 9-to-3 top-20 pharma win ...